ValuEngine upgraded shares of MetLife, Inc. (NYSE:MET) from a buy rating to a strong-buy rating in a research report sent to investors on Friday morning.

MET has been the topic of several other research reports. Wells Fargo & Company restated a buy rating on shares of MetLife in a research report on Monday, August 7th. BidaskClub upgraded shares of MetLife from a sell rating to a hold rating in a research report on Wednesday, August 9th. Keefe, Bruyette & Woods restated a buy rating and issued a $59.00 price target on shares of MetLife in a research report on Thursday, August 3rd. Zacks Investment Research lowered shares of MetLife from a hold rating to a sell rating in a research report on Wednesday, August 9th. Finally, TheStreet upgraded shares of MetLife from a c rating to a b- rating in a research report on Monday, July 24th. Two research analysts have rated the stock with a sell rating, six have assigned a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the company’s stock. MetLife has a consensus rating of Hold and a consensus target price of $59.17.

Shares of MetLife (NYSE MET) opened at 47.58 on Friday. MetLife has a 12-month low of $40.03 and a 12-month high of $58.09. The stock has a market capitalization of $50.57 billion, a P/E ratio of 559.76 and a beta of 1.46. The stock has a 50 day moving average price of $49.32 and a 200 day moving average price of $51.65.

MetLife (NYSE:MET) last posted its quarterly earnings results on Wednesday, August 2nd. The financial services provider reported $1.30 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.28 by $0.02. The firm had revenue of $17.39 billion for the quarter, compared to analyst estimates of $17.11 billion. MetLife had a net margin of 0.30% and a return on equity of 8.51%. The firm’s quarterly revenue was up 2.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.83 earnings per share. On average, equities analysts anticipate that MetLife will post $4.88 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “MetLife, Inc. (MET) Raised to Strong-Buy at ValuEngine” was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece on another publication, it was stolen and republished in violation of international copyright and trademark legislation. The correct version of this piece can be accessed at https://www.thecerbatgem.com/2017/08/15/metlife-inc-met-raised-to-strong-buy-at-valuengine.html.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 13th. Shareholders of record on Monday, August 7th will be paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 3.36%. The ex-dividend date is Thursday, August 3rd. MetLife’s dividend payout ratio (DPR) is currently 1,777.98%.

Several large investors have recently modified their holdings of the stock. Macquarie Group Ltd. raised its stake in shares of MetLife by 10.0% in the fourth quarter. Macquarie Group Ltd. now owns 325,781 shares of the financial services provider’s stock worth $17,557,000 after buying an additional 29,682 shares during the period. Carroll Financial Associates Inc. raised its stake in shares of MetLife by 15.0% in the first quarter. Carroll Financial Associates Inc. now owns 2,847 shares of the financial services provider’s stock worth $150,000 after buying an additional 372 shares during the period. First National Bank of Omaha bought a new stake in shares of MetLife during the first quarter worth about $206,000. Foothills Asset Management Ltd. bought a new stake in shares of MetLife during the first quarter worth about $2,237,000. Finally, Alpha Windward LLC raised its stake in shares of MetLife by 0.9% in the first quarter. Alpha Windward LLC now owns 3,297 shares of the financial services provider’s stock worth $174,000 after buying an additional 29 shares during the period. 75.61% of the stock is owned by institutional investors.

About MetLife

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings; Brighthouse Financial, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for MetLife (NYSE:MET)

Receive News & Stock Ratings for MetLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife Inc. and related stocks with our FREE daily email newsletter.